PBM
ACHV icon

Propel Bio Management’s Achieve Life Sciences ACHV Stock Holding History

Propel Bio Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Hold
3,786,425
– – 7.17% 2
2025
Q4 		$18.8M Hold
3,786,425
– – 16.07% 2
2025
Q3 		$11.9M Sell
3,786,425
-2,366,666
-38% -$6.5M 11.94% 2
2025
Q2 		$13.9M Buy
6,153,091
+3,699,999
+151% +$10.5M 16.88% 2
2025
Q1 		$6.55M Hold
2,453,092
– – 7.61% 5
2024
Q4 		$8.63M Hold
2,453,092
– – 8.58% 4
2024
Q3 		$11.6M Hold
2,453,092
– – 6.74% 4
2024
Q2 		$11.5M Hold
2,453,092
– – 7.48% 5
2024
Q1 		$11.1M Buy
+2,453,092
New +$10.9M 6.49% 5

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $6.49B AUM 10.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return